<DOC>
	<DOCNO>NCT02090582</DOCNO>
	<brief_summary>The purpose study test effect gynecologic oncologists palliative care specialist collaboration ( GO-PC ) intervention patient quality life .</brief_summary>
	<brief_title>H.O.P.E : Helping Ovarian Cancer Patients Cope</brief_title>
	<detailed_description>Eligible patient include woman diagnose platinum-resistant ovarian cancer recurrent ovarian cancer cancer . All patient participant complete two quality life ( QOL ) questionnaires cost-diary document health care experience time consent every 12 week thereafter . Consenting care giver also ask complete two questionnaire asses impact structure palliative care every 12 week . Patients assign two arm randomly : 1 ) usual care 2 ) structure palliative care . The primary endpoint quality life . A two-sided Chi-square test use compare proportion patient improve quality life treatment control arm intervention arm . The average value multiple score treatment use compare baseline score treatment question standard questionnaire .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Platinumresistant ovarian cancer recurrent ovarian cancer Ability read respond question English Platinumsensitive recurrent ovarian cancer without significant clinical event Existence comorbid disease , opinion investigator prohibit participation protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>